FeatureName:MLH1_silencing|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:257|Direction:-1|PValue:0.0483347|FDR:0.199442;FeatureName:SYNE1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:455|Direction:-1|PValue:0.0273861|FDR:0.397935;FeatureName:DNAH2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:291|Direction:-1|PValue:0.0149008|FDR:0.200283;FeatureName:FBXW7_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:322|Direction:-1|PValue:0.0386879|FDR:0.448135;FeatureName:CSMD3_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:300|Direction:-1|PValue:0.0199042|FDR:0.245535;FeatureName:SMAD4_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:256|Direction:-1|PValue:0.0487867|FDR:0.565112;FeatureName:FAT2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:281|Direction:-1|PValue:0.0482493|FDR:0.367968;FeatureName:PKHD1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:531|Direction: 1|PValue:0.0339216|FDR:0.823986
FeatureName:distant_metastasis_pathologic_spread|Type:BIN|StatisticMethod:ranktest|GroupComparison:m0/m1|Statistics:236.000000|Direction:-1|PValue:0.0147249|FDR:0.146038;FeatureName:tumor_stage|Type:CAT|StatisticMethod:kruskal|GroupComparison:stage ii/stage i/stage iii/stage iv|Statistics:  8.918194|Direction: 1|PValue:0.0303986|FDR:0.176058;FeatureName:hypermutated|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:640.000000|Direction: 1|PValue:0.0225713|FDR:0.072963;FeatureName:SYNE1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:867.000000|Direction: 1|PValue:0.0475008|FDR:0.397935;FeatureName:HMCN1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:730.000000|Direction: 1|PValue:0.0459866|FDR:0.674052;FeatureName:19p13.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.212441|Direction: 1|PValue:0.0469093|FDR:0.846732;FeatureName:10q22.3_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.211983|Direction:-1|PValue:0.0473968|FDR:0.941165;FeatureName:10q21.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.219908|Direction:-1|PValue:0.0395234|FDR:0.549375;FeatureName:19p13.3_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.211971|Direction: 1|PValue:0.0474095|FDR:0.828579
FeatureName:vascular_Invasion|Type:BIN|StatisticMethod:ranktest|GroupComparison:no/yes|Statistics: 535.000000|Direction: 1|PValue:0.02706415|FDR:0.5573253;FeatureName:hypermutated|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 268.000000|Direction:-1|PValue:0.00832448|FDR:0.0340324;FeatureName:silent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.334223|Direction: 1|PValue:0.00411316|FDR:0.0186145;FeatureName:TP53_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:1261.000000|Direction: 1|PValue:0.00145533|FDR:0.0168576;FeatureName:20q11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.228109|Direction:-1|PValue:0.03255509|FDR:0.0822756;FeatureName:20q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.225886|Direction:-1|PValue:0.03433381|FDR:0.0859750;FeatureName:16q23.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.295332|Direction:-1|PValue:0.00521501|FDR:0.0241629
FeatureName:distant_metastasis_pathologic_spread|Type:BIN|StatisticMethod:ranktest|GroupComparison:m0/m1|Statistics:262.000000|Direction:-1|PValue:0.0341080|FDR:0.201528;FeatureName:lymphnode_pathologic_spread|Type:CAT|StatisticMethod:kruskal|GroupComparison:n0/n1/n2|Statistics:  9.113672|Direction: 1|PValue:0.0104952|FDR:0.298307;FeatureName:SYNE1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:885.000000|Direction: 1|PValue:0.0303713|FDR:0.397935;FeatureName:HMCN1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:748.000000|Direction: 1|PValue:0.0279578|FDR:0.647689;FeatureName:KRAS_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:658.000000|Direction:-1|PValue:0.0349523|FDR:0.373721;FeatureName:10q22.3_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.260716|Direction:-1|PValue:0.0141533|FDR:0.552720;FeatureName:10q21.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.225967|Direction:-1|PValue:0.0342669|FDR:0.549375
FeatureName:lymphnode_pathologic_spread|Type:CAT|StatisticMethod:kruskal|GroupComparison:n0/n1/n2|Statistics:  7.578185|Direction: 1|PValue:0.02261612|FDR:0.2983074;FeatureName:LRP1B_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:314.000000|Direction:-1|PValue:0.03059693|FDR:0.3544144;FeatureName:KRAS_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:638.000000|Direction:-1|PValue:0.02207582|FDR:0.3737211;FeatureName:16p11.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.223119|Direction:-1|PValue:0.03666008|FDR:0.0917439;FeatureName:16q23.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.247594|Direction:-1|PValue:0.02003119|FDR:0.0632804;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.240982|Direction: 1|PValue:0.02371416|FDR:0.0672708;FeatureName:18q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.280226|Direction: 1|PValue:0.00818417|FDR:0.0291692
FeatureName:KRAS_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:655.000000|Direction:-1|PValue:0.0326890|FDR:0.3737211;FeatureName:16p11.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.256092|Direction:-1|PValue:0.0160262|FDR:0.0473968;FeatureName:16p13.3_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.233907|Direction:-1|PValue:0.0282792|FDR:0.1871815;FeatureName:16q23.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.237643|Direction:-1|PValue:0.0257837|FDR:0.0780485;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.211338|Direction: 1|PValue:0.0480908|FDR:0.1078165;FeatureName:18q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.254889|Direction: 1|PValue:0.0165475|FDR:0.0489384
FeatureName:lymphatic_invasion_present|Type:BIN|StatisticMethod:ranktest|GroupComparison:yes/no|Statistics:564.000000|Direction:-1|PValue:0.01196765|FDR:0.352811;FeatureName:number_of_lymphnodes_examined|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.243144|Direction: 1|PValue:0.02093267|FDR:0.998647;FeatureName:DMD_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:250.000000|Direction:-1|PValue:0.04046139|FDR:0.328860;FeatureName:CUBN_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:295.000000|Direction:-1|PValue:0.01696851|FDR:0.107210;FeatureName:SMAD4_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:253.000000|Direction:-1|PValue:0.04445984|FDR:0.565112;FeatureName:13q12.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.245822|Direction:-1|PValue:0.02096619|FDR:0.132468;FeatureName:4q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.274749|Direction: 1|PValue:0.00958127|FDR:0.596556;FeatureName:4q35.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.225365|Direction: 1|PValue:0.03476153|FDR:0.184998
FeatureName:overall_survival|Type:SUR|StatisticMethod:Cox model|GroupComparison:|Statistics: -4.299708|Direction:-1|PValue:0.04697585|FDR:0.5936039;FeatureName:MSI_status_TCGAPaper_threegroup|Type:CAT|StatisticMethod:kruskal|GroupComparison:MSS/MSI-L/MSI-H|Statistics:  9.451841|Direction: 1|PValue:0.00886255|FDR:0.0615947;FeatureName:FAT4_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:414.000000|Direction:-1|PValue:0.04260261|FDR:0.4815366;FeatureName:8q24.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.292596|Direction: 1|PValue:0.00566854|FDR:0.3939637;FeatureName:8p11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.264064|Direction: 1|PValue:0.01291811|FDR:0.9639189;FeatureName:8q12.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.212993|Direction: 1|PValue:0.04632647|FDR:0.6439379;FeatureName:2q33.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.268773|Direction: 1|PValue:0.01134007|FDR:0.3515832;FeatureName:4q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.230411|Direction: 1|PValue:0.03079670|FDR:0.6115345
FeatureName:synchronous_colon_cancer_present|Type:BIN|StatisticMethod:ranktest|GroupComparison:no/yes|Statistics:171.000000|Direction:-1|PValue:0.02649540|FDR:0.4949584;FeatureName:DMD_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:640.000000|Direction: 1|PValue:0.00233414|FDR:0.1081486;FeatureName:ANK2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:419.000000|Direction:-1|PValue:0.02860968|FDR:0.5626739;FeatureName:CSMD3_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:672.000000|Direction: 1|PValue:0.03868791|FDR:0.3349371;FeatureName:MDN1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:539.000000|Direction: 1|PValue:0.00500720|FDR:0.1733349;FeatureName:FAT2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:253.000000|Direction:-1|PValue:0.01988288|FDR:0.3021023;FeatureName:8p11.23_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.217102|Direction:-1|PValue:0.04217594|FDR:0.9711358;FeatureName:16p11.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.228826|Direction: 1|PValue:0.03199913|FDR:0.0839223;FeatureName:4q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.253500|Direction:-1|PValue:0.01716708|FDR:0.5965559;FeatureName:4q35.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.308140|Direction:-1|PValue:0.00349243|FDR:0.1377263;FeatureName:15q21.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.237865|Direction:-1|PValue:0.02564123|FDR:0.3240119
FeatureName:gender|Type:BIN|StatisticMethod:ranktest|GroupComparison:male/female|Statistics:1277.000000|Direction: 1|PValue:0.029404913|FDR:0.9528293;FeatureName:overall_survival|Type:SUR|StatisticMethod:Cox model|GroupComparison:|Statistics:  -4.761422|Direction:-1|PValue:0.031296530|FDR:0.5437772;FeatureName:ANK2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics: 392.000000|Direction:-1|PValue:0.013374656|FDR:0.4647693;FeatureName:RYR1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 734.000000|Direction: 1|PValue:0.016236833|FDR:0.2398475;FeatureName:MDN1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 583.000000|Direction: 1|PValue:0.000592525|FDR:0.0823609;FeatureName:SMAD4_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics: 611.000000|Direction: 1|PValue:0.007713398|FDR:0.5651123;FeatureName:TTN_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics: 630.000000|Direction:-1|PValue:0.021910601|FDR:0.2537978;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.232078|Direction:-1|PValue:0.029573519|FDR:0.0734057;FeatureName:18q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.221097|Direction:-1|PValue:0.038441962|FDR:0.0989525;FeatureName:18p11.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.219955|Direction:-1|PValue:0.039480226|FDR:0.1016250
FeatureName:TTN_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:655.000000|Direction:-1|PValue:0.0388631|FDR:0.337623;FeatureName:12p13.32_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.269152|Direction: 1|PValue:0.0112209|FDR:0.223174;FeatureName:1q31.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.245304|Direction:-1|PValue:0.0212468|FDR:0.247056;FeatureName:3p14.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.243972|Direction: 1|PValue:0.0219829|FDR:0.160822;FeatureName:12p13.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.211890|Direction: 1|PValue:0.0474959|FDR:0.388349
FeatureName:tumor_stage|Type:CAT|StatisticMethod:kruskal|GroupComparison:stage ii/stage i/stage iii/stage iv|Statistics:   8.319210|Direction: 1|PValue:0.03985531|FDR:0.1812395;FeatureName:MSI_status_TCGAPaper_threegroup|Type:CAT|StatisticMethod:kruskal|GroupComparison:MSS/MSI-L/MSI-H|Statistics:   6.525063|Direction: 1|PValue:0.03829134|FDR:0.1237790;FeatureName:KRAS_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:1163.000000|Direction: 1|PValue:0.01865732|FDR:0.3737211;FeatureName:FLG_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 677.000000|Direction: 1|PValue:0.03344240|FDR:0.2021084;FeatureName:20q11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.237065|Direction: 1|PValue:0.02615687|FDR:0.0684573;FeatureName:17q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.249414|Direction: 1|PValue:0.01910766|FDR:0.2991727;FeatureName:16p11.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.289947|Direction: 1|PValue:0.00614059|FDR:0.0237095;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.287332|Direction:-1|PValue:0.00664025|FDR:0.0249785;FeatureName:4q35.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.223965|Direction:-1|PValue:0.03593489|FDR:0.1849981;FeatureName:18q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.320395|Direction:-1|PValue:0.00234041|FDR:0.0109623;FeatureName:18p11.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.273717|Direction:-1|PValue:0.00986688|FDR:0.0351666
FeatureName:lymphnode_pathologic_spread|Type:CAT|StatisticMethod:kruskal|GroupComparison:n0/n1/n2|Statistics: 6.027544|Direction: 1|PValue:0.04910610|FDR:0.3044832;FeatureName:20q11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: 0.220660|Direction: 1|PValue:0.03883671|FDR:0.0914966;FeatureName:11p15.5_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:-0.328705|Direction:-1|PValue:0.00176712|FDR:0.1557346;FeatureName:3p14.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: 0.237788|Direction: 1|PValue:0.02569061|FDR:0.1700474;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:-0.235777|Direction:-1|PValue:0.02700562|FDR:0.0696357
FeatureName:LRP1B_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:257|Direction:-1|PValue:0.00454517|FDR:0.251504;FeatureName:ATM_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:146|Direction:-1|PValue:0.04315017|FDR:0.366533
FeatureName:TP53_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:659.000000|Direction:-1|PValue:0.0318310|FDR:0.134076;FeatureName:17q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.211486|Direction:-1|PValue:0.0479308|FDR:0.309769
FeatureName:number_of_lymphnodes_positive_by_he|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:-0.224567|Direction:-1|PValue:0.034369|FDR:0.488742
FeatureName:gender|Type:BIN|StatisticMethod:ranktest|GroupComparison:male/female|Statistics:724.000000|Direction:-1|PValue:0.021341874|FDR:0.9528293;FeatureName:silent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.293094|Direction:-1|PValue:0.012468610|FDR:0.0495182;FeatureName:SYNE1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:866.000000|Direction: 1|PValue:0.048653253|FDR:0.3979352;FeatureName:CSMD3_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:668.000000|Direction: 1|PValue:0.043373151|FDR:0.3349371;FeatureName:COL6A3_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:529.000000|Direction: 1|PValue:0.036284697|FDR:0.3981367;FeatureName:MUC16_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:864.000000|Direction: 1|PValue:0.012605255|FDR:0.0622380;FeatureName:13q12.13_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.232037|Direction: 1|PValue:0.029602903|FDR:0.1418898;FeatureName:13q22.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.284640|Direction: 1|PValue:0.007191988|FDR:0.0526151;FeatureName:2q33.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.257389|Direction: 1|PValue:0.015480296|FDR:0.3515832;FeatureName:1p33_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.385932|Direction:-1|PValue:0.000204366|FDR:0.0284069;FeatureName:1p36.11_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.317518|Direction:-1|PValue:0.002574830|FDR:0.0240971;FeatureName:7q31.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.363796|Direction: 1|PValue:0.000493781|FDR:0.0171589;FeatureName:1p13.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.278851|Direction:-1|PValue:0.008517117|FDR:0.1479849
FeatureName:synchronous_colon_cancer_present|Type:BIN|StatisticMethod:ranktest|GroupComparison:no/yes|Statistics:494.000000|Direction: 1|PValue:0.0189519|FDR:0.439053;FeatureName:FAT2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:614.000000|Direction: 1|PValue:0.0267626|FDR:0.302102;FeatureName:11p15.5_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.249594|Direction:-1|PValue:0.0190186|FDR:0.224238
FeatureName:number_of_lymphnodes_positive_by_he|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.215875|Direction:1|PValue:0.0421746|FDR:0.488742;FeatureName:preoperative_pretreatment_cea_level|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.287494|Direction:1|PValue:0.0223315|FDR:0.732980;FeatureName:FLG_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:694.000000|Direction:1|PValue:0.0199042|FDR:0.184446
FeatureName:overall_survival|Type:SUR|StatisticMethod:Cox model|GroupComparison:|Statistics: -4.451782|Direction:-1|PValue:0.03593588|FDR:0.5550097;FeatureName:FBXW7_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:247.000000|Direction:-1|PValue:0.00311559|FDR:0.2913457;FeatureName:MDN1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:184.000000|Direction:-1|PValue:0.02447810|FDR:0.2126535;FeatureName:CSMD1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:764.000000|Direction: 1|PValue:0.01741836|FDR:0.5229310;FeatureName:3p14.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.343729|Direction:-1|PValue:0.00104223|FDR:0.0423029;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.290635|Direction: 1|PValue:0.00601474|FDR:0.0245897;FeatureName:18q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.268302|Direction: 1|PValue:0.01149007|FDR:0.0347200;FeatureName:3p26.3_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.302085|Direction:-1|PValue:0.00423058|FDR:0.3490183
FeatureName:MDN1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:192.000000|Direction:-1|PValue:0.03273826|FDR:0.2395062;FeatureName:RYR2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:364.000000|Direction:-1|PValue:0.01030551|FDR:0.3136112;FeatureName:FAM123B_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:177.000000|Direction:-1|PValue:0.01879761|FDR:0.4354779;FeatureName:11p15.5_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.258092|Direction:-1|PValue:0.01519125|FDR:0.2242382;FeatureName:3p14.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.339386|Direction:-1|PValue:0.00121735|FDR:0.0423029;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.249780|Direction: 1|PValue:0.01892669|FDR:0.0584625;FeatureName:10q21.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.288598|Direction: 1|PValue:0.00639400|FDR:0.3404492;FeatureName:10q23.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.258164|Direction: 1|PValue:0.01516218|FDR:0.5268859;FeatureName:15q11.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.220466|Direction: 1|PValue:0.03901287|FDR:0.4066697;FeatureName:3p26.3_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.273091|Direction:-1|PValue:0.01004369|FDR:0.3490183
FeatureName:SYNE1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:473.000000|Direction:-1|PValue:0.0431181|FDR:0.3979352;FeatureName:DMD_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:236.000000|Direction:-1|PValue:0.0255948|FDR:0.3288605;FeatureName:TTN_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:600.000000|Direction:-1|PValue:0.0103102|FDR:0.1989302;FeatureName:20q11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.251357|Direction:-1|PValue:0.0181626|FDR:0.0495020;FeatureName:20q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.229928|Direction:-1|PValue:0.0311592|FDR:0.0802061;FeatureName:13q22.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.236619|Direction:-1|PValue:0.0264484|FDR:0.1470532;FeatureName:20q13.31_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.271751|Direction:-1|PValue:0.0104315|FDR:0.0315211;FeatureName:19p13.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.236658|Direction:-1|PValue:0.0264230|FDR:0.7345581;FeatureName:1p33_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.249545|Direction: 1|PValue:0.0190426|FDR:0.2646928;FeatureName:1p36.11_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.251028|Direction: 1|PValue:0.0183197|FDR:0.1011444;FeatureName:19p13.3_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.255323|Direction:-1|PValue:0.0163577|FDR:0.5684302
FeatureName:tissue_site|Type:CAT|StatisticMethod:kruskal|GroupComparison:aa/ag/af/a6|Statistics: 10.076280|Direction: 1|PValue:0.01792873|FDR:0.431313;FeatureName:lymphnode_pathologic_spread|Type:CAT|StatisticMethod:kruskal|GroupComparison:n0/n1/n2|Statistics:  7.621911|Direction: 1|PValue:0.02212703|FDR:0.298307;FeatureName:person_neoplasm_cancer_status|Type:BIN|StatisticMethod:ranktest|GroupComparison:with tumor/tumor free|Statistics:356.000000|Direction: 1|PValue:0.01177210|FDR:0.545441;FeatureName:tumor_stage|Type:CAT|StatisticMethod:kruskal|GroupComparison:stage ii/stage i/stage iii/stage iv|Statistics:  8.287977|Direction: 1|PValue:0.04042032|FDR:0.181240;FeatureName:CUBN_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:680.000000|Direction: 1|PValue:0.03059693|FDR:0.157518;FeatureName:CSMD2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:581.000000|Direction: 1|PValue:0.02311169|FDR:0.450530;FeatureName:11p15.5_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.253795|Direction:-1|PValue:0.01703415|FDR:0.224238;FeatureName:16p13.3_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.278599|Direction: 1|PValue:0.00857938|FDR:0.129677;FeatureName:16q23.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.219238|Direction: 1|PValue:0.04014370|FDR:0.109411;FeatureName:10q21.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.221079|Direction: 1|PValue:0.03845788|FDR:0.549375
FeatureName:SYNE1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:937.000000|Direction: 1|PValue:0.00703773|FDR:0.397935;FeatureName:FAT2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:597.000000|Direction: 1|PValue:0.04545621|FDR:0.367968;FeatureName:11p15.5_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.262566|Direction:-1|PValue:0.01345859|FDR:0.224238
FeatureName:synchronous_colon_cancer_present|Type:BIN|StatisticMethod:ranktest|GroupComparison:no/yes|Statistics:173.000000|Direction:-1|PValue:0.0284868|FDR:0.494958;FeatureName:13q12.13_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.218625|Direction:-1|PValue:0.0407180|FDR:0.184133;FeatureName:1p36.11_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.241269|Direction:-1|PValue:0.0235427|FDR:0.105443;FeatureName:15q21.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.225016|Direction:-1|PValue:0.0350512|FDR:0.374778;FeatureName:3p26.3_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.213535|Direction: 1|PValue:0.0457600|FDR:0.652326
FeatureName:gender|Type:BIN|StatisticMethod:ranktest|GroupComparison:male/female|Statistics:644.000000|Direction:-1|PValue:0.00298323|FDR:0.414669;FeatureName:FBXW7_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:331.000000|Direction:-1|PValue:0.04989556|FDR:0.488590;FeatureName:DNAH5_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:683.000000|Direction: 1|PValue:0.02796194|FDR:0.973636;FeatureName:RYR1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:736.000000|Direction: 1|PValue:0.01524090|FDR:0.239848;FeatureName:1q31.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.236868|Direction:-1|PValue:0.02628539|FDR:0.247056;FeatureName:16p13.3_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.247113|Direction: 1|PValue:0.02028153|FDR:0.187181;FeatureName:1p33_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.249959|Direction:-1|PValue:0.01883840|FDR:0.264693
FeatureName:Cancer|Type:BIN|StatisticMethod:ranktest|GroupComparison:colon/rectum|Statistics: 626.000000|Direction:-1|PValue:0.0330446|FDR:0.3610972;FeatureName:anatomic_organ_subdivision|Type:CAT|StatisticMethod:kruskal|GroupComparison:transverse colon/ascending colon/hepatic flexure/rectum/sigmoid colon/rectosigmoid junction/cecum/descending colon|Statistics:  15.886774|Direction: 1|PValue:0.0261712|FDR:0.4213227;FeatureName:tissue_site|Type:CAT|StatisticMethod:kruskal|GroupComparison:aa/ag/af/a6|Statistics:   9.283142|Direction: 1|PValue:0.0257539|FDR:0.4313129;FeatureName:history_of_colon_polyps|Type:BIN|StatisticMethod:ranktest|GroupComparison:no/yes|Statistics:1177.000000|Direction: 1|PValue:0.0481545|FDR:0.9957516;FeatureName:lymphatic_invasion_present|Type:BIN|StatisticMethod:ranktest|GroupComparison:yes/no|Statistics:1095.000000|Direction: 1|PValue:0.0140692|FDR:0.3528112;FeatureName:lymphnode_pathologic_spread|Type:CAT|StatisticMethod:kruskal|GroupComparison:n0/n1/n2|Statistics:   8.425316|Direction: 1|PValue:0.0148070|FDR:0.2983074;FeatureName:tumor_stage|Type:CAT|StatisticMethod:kruskal|GroupComparison:stage ii/stage i/stage iii/stage iv|Statistics:  10.560861|Direction: 1|PValue:0.0143537|FDR:0.1523544;FeatureName:FAT2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 613.000000|Direction: 1|PValue:0.0276412|FDR:0.3021023;FeatureName:20q11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.226436|Direction: 1|PValue:0.0338859|FDR:0.0829645;FeatureName:20q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.254902|Direction: 1|PValue:0.0165419|FDR:0.0499853;FeatureName:15q11.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.212997|Direction:-1|PValue:0.0463217|FDR:0.4066697;FeatureName:18p11.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.229643|Direction:-1|PValue:0.0313741|FDR:0.0855099
FeatureName:vascular_Invasion|Type:BIN|StatisticMethod:ranktest|GroupComparison:no/yes|Statistics: 544.000000|Direction: 1|PValue:0.01916282|FDR:0.5573253;FeatureName:TP53_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:1200.000000|Direction: 1|PValue:0.00867585|FDR:0.0651831;FeatureName:TTN_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics: 664.000000|Direction:-1|PValue:0.04720325|FDR:0.3527352;FeatureName:13q12.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.225849|Direction:-1|PValue:0.03436332|FDR:0.1627895;FeatureName:13q12.13_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.210110|Direction:-1|PValue:0.04943590|FDR:0.2020541;FeatureName:13q22.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.250128|Direction:-1|PValue:0.01875586|FDR:0.1185029;FeatureName:20q13.31_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.249040|Direction:-1|PValue:0.01929440|FDR:0.0515754;FeatureName:1q31.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.398012|Direction:-1|PValue:0.00012292|FDR:0.0170859;FeatureName:8p23.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.222177|Direction: 1|PValue:0.03748100|FDR:0.3123669
FeatureName:primary_tumor_pathologic_spread|Type:CAT|StatisticMethod:kruskal|GroupComparison:t3/t2/t1/t4|Statistics: 9.178390|Direction: 1|PValue:0.02701076|FDR:0.645470;FeatureName:17q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:-0.243345|Direction:-1|PValue:0.02233627|FDR:0.299173;FeatureName:11p15.5_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: 0.280823|Direction: 1|PValue:0.00804343|FDR:0.186339
FeatureName:FBXW7_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 329.000000|Direction:-1|PValue:0.04719407|FDR:0.488590;FeatureName:TP53_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:1143.000000|Direction: 1|PValue:0.03479946|FDR:0.135430;FeatureName:KRAS_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:1163.000000|Direction: 1|PValue:0.01865732|FDR:0.373721;FeatureName:PIK3CA_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics: 739.000000|Direction: 1|PValue:0.03602040|FDR:0.832001;FeatureName:ATM_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 133.000000|Direction:-1|PValue:0.02574253|FDR:0.366533;FeatureName:8q24.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.231912|Direction:-1|PValue:0.02969348|FDR:0.515924;FeatureName:8q12.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.295705|Direction:-1|PValue:0.00515572|FDR:0.358323;FeatureName:5q11.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.270208|Direction: 1|PValue:0.01089397|FDR:0.504754;FeatureName:8q11.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.229279|Direction:-1|PValue:0.03165150|FDR:0.881211;FeatureName:12p13.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.276312|Direction: 1|PValue:0.00916273|FDR:0.212270
FeatureName:preoperative_pretreatment_cea_level|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:-0.269516|Direction:-1|PValue:0.03267267|FDR:0.732980;FeatureName:primary_tumor_pathologic_spread|Type:CAT|StatisticMethod:kruskal|GroupComparison:t3/t2/t1/t4|Statistics: 9.374849|Direction: 1|PValue:0.02470071|FDR:0.645470;FeatureName:tumor_stage|Type:CAT|StatisticMethod:kruskal|GroupComparison:stage ii/stage i/stage iii/stage iv|Statistics: 9.020496|Direction: 1|PValue:0.02901962|FDR:0.176058;FeatureName:11p15.5_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: 0.215969|Direction: 1|PValue:0.04328788|FDR:0.287103;FeatureName:15q21.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: 0.274167|Direction: 1|PValue:0.00974143|FDR:0.249888
FeatureName:Cancer|Type:BIN|StatisticMethod:ranktest|GroupComparison:colon/rectum|Statistics:1147.000000|Direction: 1|PValue:0.01550279|FDR:0.269361;FeatureName:histological_type|Type:CAT|StatisticMethod:kruskal|GroupComparison:colon adenocarcinoma/rectal adenocarcinoma/rectal mucinous adenocarcinoma/colon mucinous adenocarcinoma|Statistics:   8.623407|Direction: 1|PValue:0.03474047|FDR:0.406381;FeatureName:SMAD4_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics: 231.000000|Direction:-1|PValue:0.02157496|FDR:0.565112;FeatureName:1p33_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.256857|Direction:-1|PValue:0.01570260|FDR:0.264693;FeatureName:1p36.11_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.230709|Direction:-1|PValue:0.03057495|FDR:0.118053;FeatureName:8p22_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.210085|Direction:-1|PValue:0.04946361|FDR:0.286477;FeatureName:1p13.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.281519|Direction:-1|PValue:0.00788174|FDR:0.147985
FeatureName:MSI_status_TCGAPaper_threegroup|Type:CAT|StatisticMethod:kruskal|GroupComparison:MSS/MSI-L/MSI-H|Statistics:   8.191409|Direction: 1|PValue:0.01664401|FDR:0.0839819;FeatureName:MSI_status_TCGAPaper_twogroup|Type:BIN|StatisticMethod:ranktest|GroupComparison:MSS/MSI|Statistics: 441.000000|Direction:-1|PValue:0.02124129|FDR:0.0988597;FeatureName:silent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.249666|Direction: 1|PValue:0.03442726|FDR:0.1040302;FeatureName:nonsilent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.284024|Direction: 1|PValue:0.01561195|FDR:0.0770916;FeatureName:CUBN_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 306.000000|Direction:-1|PValue:0.02400430|FDR:0.1334639;FeatureName:TP53_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:1161.000000|Direction: 1|PValue:0.02307328|FDR:0.1159027;FeatureName:FAT4_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics: 858.000000|Direction: 1|PValue:0.00619065|FDR:0.3062841;FeatureName:20q11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.293864|Direction:-1|PValue:0.00545421|FDR:0.0194394;FeatureName:20q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.257182|Direction:-1|PValue:0.01556633|FDR:0.0480827;FeatureName:20q13.31_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.301611|Direction:-1|PValue:0.00429374|FDR:0.0170523;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.227014|Direction: 1|PValue:0.03342124|FDR:0.0800957
FeatureName:DMD_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:129.000000|Direction:-1|PValue:0.000279902|FDR:0.0389063;FeatureName:8q24.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.257600|Direction:-1|PValue:0.015393326|FDR:0.5159243;FeatureName:5q22.3_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.295101|Direction: 1|PValue:0.005251937|FDR:0.2738891;FeatureName:5q11.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.316060|Direction: 1|PValue:0.002701459|FDR:0.3755028;FeatureName:5q22.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.315650|Direction: 1|PValue:0.002738097|FDR:0.3226015;FeatureName:1p13.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.231386|Direction:-1|PValue:0.030076119|FDR:0.2200306;FeatureName:14q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.270846|Direction:-1|PValue:0.010700537|FDR:0.1444141
FeatureName:person_neoplasm_cancer_status|Type:BIN|StatisticMethod:ranktest|GroupComparison:with tumor/tumor free|Statistics:345.000000|Direction: 1|PValue:0.0200644|FDR:0.549580;FeatureName:APC_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:438.000000|Direction:-1|PValue:0.0106625|FDR:0.293146;FeatureName:17q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.258848|Direction:-1|PValue:0.0148858|FDR:0.295589;FeatureName:12p13.32_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.212309|Direction: 1|PValue:0.0470488|FDR:0.362303;FeatureName:3p14.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.238317|Direction: 1|PValue:0.0253542|FDR:0.170047
FeatureName:distant_metastasis_pathologic_spread|Type:BIN|StatisticMethod:ranktest|GroupComparison:m0/m1|Statistics:605.000000|Direction: 1|PValue:0.03624612|FDR:0.201528;FeatureName:lymphnode_pathologic_spread|Type:CAT|StatisticMethod:kruskal|GroupComparison:n0/n1/n2|Statistics:  6.123539|Direction: 1|PValue:0.04680480|FDR:0.304483;FeatureName:person_neoplasm_cancer_status|Type:BIN|StatisticMethod:ranktest|GroupComparison:with tumor/tumor free|Statistics:327.000000|Direction: 1|PValue:0.04463513|FDR:0.614374;FeatureName:APC_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:431.000000|Direction:-1|PValue:0.00869537|FDR:0.293146;FeatureName:DCHS2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:211.000000|Direction:-1|PValue:0.02573938|FDR:0.264681;FeatureName:17q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.216348|Direction:-1|PValue:0.04291341|FDR:0.309769
FeatureName:MLH1_silencing|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:258|Direction:-1|PValue:0.0499713|FDR:0.199442;FeatureName:SYNE1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:463|Direction:-1|PValue:0.0336320|FDR:0.397935;FeatureName:DNAH2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:303|Direction:-1|PValue:0.0218708|FDR:0.200283;FeatureName:FBXW7_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:320|Direction:-1|PValue:0.0365113|FDR:0.448135;FeatureName:CSMD3_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:302|Direction:-1|PValue:0.0211972|FDR:0.245535;FeatureName:FAT2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:276|Direction:-1|PValue:0.0415229|FDR:0.367968
FeatureName:anatomic_organ_subdivision|Type:CAT|StatisticMethod:kruskal|GroupComparison:transverse colon/ascending colon/hepatic flexure/rectum/sigmoid colon/rectosigmoid junction/cecum/descending colon|Statistics:  16.534237|Direction: 1|PValue:0.02065939|FDR:0.4213227;FeatureName:vascular_Invasion|Type:BIN|StatisticMethod:ranktest|GroupComparison:no/yes|Statistics: 521.000000|Direction: 1|PValue:0.04489512|FDR:0.5573253;FeatureName:hypermutated|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 292.000000|Direction:-1|PValue:0.02031966|FDR:0.0672484;FeatureName:silent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.333901|Direction: 1|PValue:0.00415144|FDR:0.0186145;FeatureName:nonsilent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.233168|Direction: 1|PValue:0.04870897|FDR:0.1448440;FeatureName:TP53_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:1169.000000|Direction: 1|PValue:0.01906681|FDR:0.1019341;FeatureName:CSMD1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 369.000000|Direction:-1|PValue:0.04019613|FDR:0.5229310;FeatureName:16q23.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.247902|Direction:-1|PValue:0.01987220|FDR:0.0632804
FeatureName:lymphnode_pathologic_spread|Type:CAT|StatisticMethod:kruskal|GroupComparison:n0/n1/n2|Statistics:  6.331335|Direction: 1|PValue:0.04218598|FDR:0.304483;FeatureName:SYNE1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:926.000000|Direction: 1|PValue:0.00979532|FDR:0.397935;FeatureName:10q22.3_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.276922|Direction:-1|PValue:0.00900395|FDR:0.552720;FeatureName:10q21.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.245547|Direction:-1|PValue:0.02111508|FDR:0.549375
FeatureName:hypermutated|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:629.000000|Direction: 1|PValue:0.03278054|FDR:0.089343;FeatureName:SYNE1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:880.000000|Direction: 1|PValue:0.03449246|FDR:0.397935;FeatureName:HMCN1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:755.000000|Direction: 1|PValue:0.02281164|FDR:0.647689;FeatureName:FAT2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:631.000000|Direction: 1|PValue:0.01511892|FDR:0.300219;FeatureName:KRAS_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:644.000000|Direction:-1|PValue:0.02542189|FDR:0.373721;FeatureName:LRP2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:278.000000|Direction:-1|PValue:0.00963091|FDR:0.222536;FeatureName:10q22.3_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.247883|Direction:-1|PValue:0.01988201|FDR:0.552720;FeatureName:2q33.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.224905|Direction: 1|PValue:0.03514362|FDR:0.476933;FeatureName:10q21.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.240482|Direction:-1|PValue:0.02401443|FDR:0.549375;FeatureName:8p23.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.219121|Direction:-1|PValue:0.04025255|FDR:0.312367
FeatureName:Cancer|Type:BIN|StatisticMethod:ranktest|GroupComparison:colon/rectum|Statistics:1099.000000|Direction: 1|PValue:0.0454749|FDR:0.4214010;FeatureName:MSI_status_TCGAPaper_threegroup|Type:CAT|StatisticMethod:kruskal|GroupComparison:MSS/MSI-L/MSI-H|Statistics:   6.176147|Direction: 1|PValue:0.0455897|FDR:0.1297261;FeatureName:LRP1B_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 289.000000|Direction:-1|PValue:0.0139527|FDR:0.2515037;FeatureName:KRAS_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics: 636.000000|Direction:-1|PValue:0.0210481|FDR:0.3737211;FeatureName:16p11.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.222018|Direction:-1|PValue:0.0376216|FDR:0.0917439;FeatureName:1q31.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.228634|Direction:-1|PValue:0.0321470|FDR:0.2470558;FeatureName:16q23.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.225208|Direction:-1|PValue:0.0348913|FDR:0.0970790;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.228000|Direction: 1|PValue:0.0326404|FDR:0.0795968;FeatureName:4q35.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.237906|Direction: 1|PValue:0.0256151|FDR:0.1799882;FeatureName:18q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.268689|Direction: 1|PValue:0.0113666|FDR:0.0347200
FeatureName:lymphnode_pathologic_spread|Type:CAT|StatisticMethod:kruskal|GroupComparison:n0/n1/n2|Statistics: 7.173014|Direction: 1|PValue:0.02769489|FDR:0.3044832;FeatureName:10q22.3_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:-0.228427|Direction:-1|PValue:0.03230779|FDR:0.7484639;FeatureName:16q23.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:-0.230087|Direction:-1|PValue:0.03103915|FDR:0.0917966;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: 0.219440|Direction: 1|PValue:0.03995550|FDR:0.0925636;FeatureName:18q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: 0.276422|Direction: 1|PValue:0.00913405|FDR:0.0302294
FeatureName:lymphatic_invasion_present|Type:BIN|StatisticMethod:ranktest|GroupComparison:yes/no|Statistics:543.000000|Direction:-1|PValue:0.00661721|FDR:0.306597;FeatureName:number_of_lymphnodes_examined|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.258613|Direction: 1|PValue:0.01384923|FDR:0.998647;FeatureName:CUBN_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:326.000000|Direction:-1|PValue:0.04337315|FDR:0.187610;FeatureName:SMAD4_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:247.000000|Direction:-1|PValue:0.03677208|FDR:0.565112;FeatureName:FAM123B_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:203.000000|Direction:-1|PValue:0.04790978|FDR:0.447475;FeatureName:13q12.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.229293|Direction:-1|PValue:0.03164071|FDR:0.162790;FeatureName:11p15.5_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.242909|Direction: 1|PValue:0.02258515|FDR:0.224238;FeatureName:4q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.264394|Direction: 1|PValue:0.01280185|FDR:0.596556;FeatureName:4q35.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.225718|Direction: 1|PValue:0.03447146|FDR:0.184998
FeatureName:overall_survival|Type:SUR|StatisticMethod:Cox model|GroupComparison:|Statistics: -4.955520|Direction:-1|PValue:0.0114825|FDR:0.5437772;FeatureName:distant_metastasis_pathologic_spread|Type:BIN|StatisticMethod:ranktest|GroupComparison:m0/m1|Statistics:605.000000|Direction: 1|PValue:0.0362461|FDR:0.2015284;FeatureName:nonsilent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.260598|Direction:-1|PValue:0.0270430|FDR:0.0939743;FeatureName:CSMD1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:728.000000|Direction: 1|PValue:0.0484920|FDR:0.5229310;FeatureName:LRP2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:300.000000|Direction:-1|PValue:0.0199042|FDR:0.2225364;FeatureName:1q31.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.221897|Direction:-1|PValue:0.0377280|FDR:0.2470558;FeatureName:16p13.3_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.221670|Direction: 1|PValue:0.0379295|FDR:0.2108880;FeatureName:16q23.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.250861|Direction: 1|PValue:0.0184002|FDR:0.0623694
FeatureName:number_of_lymphnodes_positive_by_he|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.215855|Direction:-1|PValue:0.04219359|FDR:0.488742;FeatureName:TTN_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:655.000000|Direction:-1|PValue:0.03886310|FDR:0.337623;FeatureName:12p13.32_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.317997|Direction: 1|PValue:0.00253437|FDR:0.176139;FeatureName:3p14.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.268865|Direction: 1|PValue:0.01131114|FDR:0.149840;FeatureName:10q25.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.213620|Direction:-1|PValue:0.04567186|FDR:0.689421;FeatureName:12p13.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.231360|Direction: 1|PValue:0.03009556|FDR:0.298806
FeatureName:synchronous_colon_cancer_present|Type:BIN|StatisticMethod:ranktest|GroupComparison:no/yes|Statistics:155.000000|Direction:-1|PValue:0.014456238|FDR:0.4179625;FeatureName:MSI_status_TCGAPaper_threegroup|Type:CAT|StatisticMethod:kruskal|GroupComparison:MSS/MSI-L/MSI-H|Statistics:  6.693478|Direction: 1|PValue:0.035198953|FDR:0.1207013;FeatureName:CSMD3_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:670.000000|Direction: 1|PValue:0.040973816|FDR:0.3349371;FeatureName:6p21.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.246353|Direction: 1|PValue:0.020682378|FDR:0.1691089;FeatureName:19p13.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.265471|Direction: 1|PValue:0.012427686|FDR:0.7345581;FeatureName:1p33_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.266432|Direction:-1|PValue:0.012102339|FDR:0.2646928;FeatureName:1p36.11_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.300924|Direction:-1|PValue:0.004387000|FDR:0.0360877;FeatureName:4q35.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.285313|Direction:-1|PValue:0.007050400|FDR:0.1400008;FeatureName:18q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.221150|Direction:-1|PValue:0.038394484|FDR:0.0989525;FeatureName:19p13.3_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.273869|Direction: 1|PValue:0.009824398|FDR:0.5684302;FeatureName:15q21.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.215232|Direction:-1|PValue:0.044025270|FDR:0.4079675;FeatureName:1p13.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.372802|Direction:-1|PValue:0.000347493|FDR:0.0483015
FeatureName:lymphnode_pathologic_spread|Type:CAT|StatisticMethod:kruskal|GroupComparison:n0/n1/n2|Statistics:  6.610665|Direction: 1|PValue:0.03668701|FDR:0.30448322;FeatureName:tumor_stage|Type:CAT|StatisticMethod:kruskal|GroupComparison:stage ii/stage i/stage iii/stage iv|Statistics:  8.737946|Direction: 1|PValue:0.03298577|FDR:0.18123951;FeatureName:FLG_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:667.000000|Direction: 1|PValue:0.04461667|FDR:0.22148988;FeatureName:20q11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.254017|Direction: 1|PValue:0.01693444|FDR:0.04707776;FeatureName:20q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.222117|Direction: 1|PValue:0.03753443|FDR:0.09153132;FeatureName:17q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.212508|Direction: 1|PValue:0.04683804|FDR:0.30976897;FeatureName:20q13.31_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.218572|Direction: 1|PValue:0.04076867|FDR:0.09770422;FeatureName:16p11.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.328275|Direction: 1|PValue:0.00179336|FDR:0.00859575;FeatureName:1q31.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.284122|Direction: 1|PValue:0.00730272|FDR:0.24189704;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.234245|Direction:-1|PValue:0.02804555|FDR:0.07087875;FeatureName:18q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.237029|Direction:-1|PValue:0.02618066|FDR:0.07278224;FeatureName:18p11.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.250385|Direction:-1|PValue:0.01863018|FDR:0.06110100
FeatureName:person_neoplasm_cancer_status|Type:BIN|StatisticMethod:ranktest|GroupComparison:with tumor/tumor free|Statistics:330.000000|Direction: 1|PValue:0.0393106|FDR:0.6071302;FeatureName:MSI_status_TCGAPaper_threegroup|Type:CAT|StatisticMethod:kruskal|GroupComparison:MSS/MSI-L/MSI-H|Statistics:  8.201874|Direction: 1|PValue:0.0165572|FDR:0.0839819;FeatureName:MSI_status_TCGAPaper_twogroup|Type:BIN|StatisticMethod:ranktest|GroupComparison:MSS/MSI|Statistics:473.000000|Direction:-1|PValue:0.0468909|FDR:0.1710653;FeatureName:MLH1_silencing|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:233.000000|Direction:-1|PValue:0.0205954|FDR:0.0987160;FeatureName:13q12.13_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.238070|Direction:-1|PValue:0.0255109|FDR:0.1368350;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.226019|Direction:-1|PValue:0.0342249|FDR:0.0806315;FeatureName:18q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.217997|Direction:-1|PValue:0.0413144|FDR:0.1025481
FeatureName:overall_survival|Type:SUR|StatisticMethod:Cox model|GroupComparison:|Statistics:  -4.275981|Direction:-1|PValue:0.03125577|FDR:0.543777;FeatureName:DMD_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 559.000000|Direction: 1|PValue:0.04730670|FDR:0.328860;FeatureName:MDN1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 503.000000|Direction: 1|PValue:0.02188319|FDR:0.202784;FeatureName:SMAD4_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics: 576.000000|Direction: 1|PValue:0.02737561|FDR:0.565112;FeatureName:KRAS_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:1192.000000|Direction: 1|PValue:0.00890948|FDR:0.373721;FeatureName:13q12.13_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.217806|Direction:-1|PValue:0.04149656|FDR:0.184133
FeatureName:lymphatic_invasion_present|Type:BIN|StatisticMethod:ranktest|GroupComparison:yes/no|Statistics:603.00000|Direction:-1|PValue:0.03232994|FDR:0.408533;FeatureName:primary_tumor_pathologic_spread|Type:CAT|StatisticMethod:kruskal|GroupComparison:t3/t2/t1/t4|Statistics:  8.51605|Direction: 1|PValue:0.03646785|FDR:0.645470;FeatureName:SYNE1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:479.00000|Direction:-1|PValue:0.04982905|FDR:0.397935;FeatureName:ANK2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:420.00000|Direction:-1|PValue:0.02938558|FDR:0.562674;FeatureName:MDN1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:548.00000|Direction: 1|PValue:0.00333424|FDR:0.154486
FeatureName:Cancer|Type:BIN|StatisticMethod:ranktest|GroupComparison:colon/rectum|Statistics:624.000000|Direction:-1|PValue:0.0316305|FDR:0.3610972;FeatureName:primary_tumor_pathologic_spread|Type:CAT|StatisticMethod:kruskal|GroupComparison:t3/t2/t1/t4|Statistics: 10.137222|Direction: 1|PValue:0.0174350|FDR:0.6454702;FeatureName:MSI_status_TCGAPaper_threegroup|Type:CAT|StatisticMethod:kruskal|GroupComparison:MSS/MSI-L/MSI-H|Statistics:  6.169967|Direction: 1|PValue:0.0457308|FDR:0.1297261;FeatureName:FLG_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:667.000000|Direction: 1|PValue:0.0446167|FDR:0.2214899;FeatureName:16p11.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.253459|Direction: 1|PValue:0.0171859|FDR:0.0497674;FeatureName:16q23.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.262282|Direction: 1|PValue:0.0135632|FDR:0.0471321;FeatureName:1p36.11_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.213481|Direction:-1|PValue:0.0458163|FDR:0.1592116;FeatureName:18q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.227438|Direction:-1|PValue:0.0330839|FDR:0.0899205;FeatureName:1p13.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.215039|Direction:-1|PValue:0.0442193|FDR:0.2284730
FeatureName:overall_survival|Type:SUR|StatisticMethod:Cox model|GroupComparison:|Statistics: -4.793904|Direction:-1|PValue:0.02712417|FDR:0.543777;FeatureName:number_of_first_degree_relatives_with_cancer_diagnosis|Type:CAT|StatisticMethod:kruskal|GroupComparison:0/1/2/3|Statistics:  8.710599|Direction: 1|PValue:0.03339667|FDR:0.895219;FeatureName:ANK2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:437.000000|Direction:-1|PValue:0.04561381|FDR:0.562674;FeatureName:1q31.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.230527|Direction: 1|PValue:0.03070985|FDR:0.247056;FeatureName:1p33_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.315057|Direction: 1|PValue:0.00279189|FDR:0.155800;FeatureName:1p13.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.215365|Direction: 1|PValue:0.04389113|FDR:0.228473
FeatureName:tumor_stage|Type:CAT|StatisticMethod:kruskal|GroupComparison:stage ii/stage i/stage iii/stage iv|Statistics:   8.980168|Direction:1|PValue:0.0295557|FDR:0.1760583;FeatureName:MSI_status_TCGAPaper_threegroup|Type:CAT|StatisticMethod:kruskal|GroupComparison:MSS/MSI-L/MSI-H|Statistics:   8.672356|Direction:1|PValue:0.0130865|FDR:0.0839819;FeatureName:APC_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics: 919.000000|Direction:1|PValue:0.0236608|FDR:0.3288855;FeatureName:SMAD4_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics: 565.000000|Direction:1|PValue:0.0391982|FDR:0.5651123;FeatureName:KRAS_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:1159.000000|Direction:1|PValue:0.0205499|FDR:0.3737211;FeatureName:17q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.241046|Direction:1|PValue:0.0236755|FDR:0.2991727;FeatureName:1p33_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.233117|Direction:1|PValue:0.0288324|FDR:0.2906047;FeatureName:1p36.11_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.229397|Direction:1|PValue:0.0315616|FDR:0.1185691
FeatureName:tumor_stage|Type:CAT|StatisticMethod:kruskal|GroupComparison:stage ii/stage i/stage iii/stage iv|Statistics:  10.002232|Direction: 1|PValue:0.0185472|FDR:0.161972;FeatureName:MSI_status_TCGAPaper_threegroup|Type:CAT|StatisticMethod:kruskal|GroupComparison:MSS/MSI-L/MSI-H|Statistics:   7.232566|Direction: 1|PValue:0.0268824|FDR:0.103796;FeatureName:SMAD4_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics: 565.000000|Direction: 1|PValue:0.0391982|FDR:0.565112;FeatureName:KRAS_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:1158.000000|Direction: 1|PValue:0.0210481|FDR:0.373721;FeatureName:17q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.230723|Direction: 1|PValue:0.0305644|FDR:0.309769;FeatureName:4q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.219298|Direction:-1|PValue:0.0400881|FDR:0.663437
FeatureName:primary_tumor_pathologic_spread|Type:CAT|StatisticMethod:kruskal|GroupComparison:t3/t2/t1/t4|Statistics:  8.331643|Direction: 1|PValue:0.03963255|FDR:0.6454702;FeatureName:LRP1B_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:711.000000|Direction: 1|PValue:0.01142036|FDR:0.2515037;FeatureName:MDN1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:503.000000|Direction: 1|PValue:0.02188319|FDR:0.2027842;FeatureName:RYR2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:843.000000|Direction: 1|PValue:0.00999037|FDR:0.3136112;FeatureName:MUC16_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:836.000000|Direction: 1|PValue:0.02785148|FDR:0.1075377;FeatureName:FLG_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:685.000000|Direction: 1|PValue:0.02631602|FDR:0.2021084;FeatureName:ATM_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:405.000000|Direction: 1|PValue:0.03553712|FDR:0.3665326;FeatureName:17q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.243636|Direction: 1|PValue:0.02217163|FDR:0.2991727;FeatureName:11p15.5_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.264583|Direction: 1|PValue:0.01273539|FDR:0.2242382;FeatureName:16p11.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.222079|Direction: 1|PValue:0.03756721|FDR:0.0917439;FeatureName:16q23.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.225173|Direction: 1|PValue:0.03492049|FDR:0.0970790;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.236050|Direction:-1|PValue:0.02682381|FDR:0.0696357;FeatureName:18q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.272106|Direction:-1|PValue:0.01032726|FDR:0.0331970
FeatureName:FAT4_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:855.000000|Direction: 1|PValue:0.00682551|FDR:0.3062841;FeatureName:RYR2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:384.000000|Direction:-1|PValue:0.01875941|FDR:0.3136112;FeatureName:FAM123B_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:148.000000|Direction:-1|PValue:0.00571462|FDR:0.2647776;FeatureName:8p11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.231517|Direction:-1|PValue:0.02998021|FDR:0.9639189;FeatureName:3p14.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.294374|Direction:-1|PValue:0.00536991|FDR:0.1066311;FeatureName:1p36.11_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.238469|Direction: 1|PValue:0.02525813|FDR:0.1061577;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.241951|Direction: 1|PValue:0.02314089|FDR:0.0670122;FeatureName:10q23.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.229759|Direction: 1|PValue:0.03128667|FDR:0.6212638;FeatureName:3p26.3_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.249742|Direction:-1|PValue:0.01894516|FDR:0.4000343
FeatureName:lymphatic_invasion_present|Type:BIN|StatisticMethod:ranktest|GroupComparison:yes/no|Statistics:1047.000000|Direction: 1|PValue:0.04572942|FDR:0.426046;FeatureName:LRP1B_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 688.000000|Direction: 1|PValue:0.02400430|FDR:0.303327;FeatureName:13q12.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.237615|Direction: 1|PValue:0.02580164|FDR:0.149434;FeatureName:11p15.5_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.294420|Direction:-1|PValue:0.00536237|FDR:0.155735;FeatureName:13q12.13_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.232759|Direction: 1|PValue:0.02908554|FDR:0.141890;FeatureName:3q26.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.232581|Direction:-1|PValue:0.02921247|FDR:0.900500;FeatureName:3p26.3_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.280057|Direction:-1|PValue:0.00822442|FDR:0.349018
FeatureName:histological_type|Type:CAT|StatisticMethod:kruskal|GroupComparison:colon adenocarcinoma/rectal adenocarcinoma/rectal mucinous adenocarcinoma/colon mucinous adenocarcinoma|Statistics: 11.886509|Direction: 1|PValue:0.007782219|FDR:0.4029875;FeatureName:FBXW7_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:320.000000|Direction:-1|PValue:0.036511285|FDR:0.4481349;FeatureName:DMD_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:201.000000|Direction:-1|PValue:0.007133441|FDR:0.1857719;FeatureName:HMCN1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:341.000000|Direction:-1|PValue:0.017956526|FDR:0.6476887;FeatureName:20q11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.254589|Direction:-1|PValue:0.016679677|FDR:0.0470778;FeatureName:20q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.261876|Direction:-1|PValue:0.013714104|FDR:0.0433241;FeatureName:12p13.32_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.363751|Direction: 1|PValue:0.000494648|FDR:0.0687560;FeatureName:13q22.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.331173|Direction:-1|PValue:0.001623241|FDR:0.0173562;FeatureName:20q13.31_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.300282|Direction:-1|PValue:0.004475724|FDR:0.0172813;FeatureName:1p36.11_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.317377|Direction: 1|PValue:0.002586837|FDR:0.0240971;FeatureName:12p13.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.276533|Direction: 1|PValue:0.009105088|FDR:0.2122700
FeatureName:silent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.291454|Direction:-1|PValue:0.01299254|FDR:0.0501656;FeatureName:nonsilent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.238361|Direction:-1|PValue:0.04376562|FDR:0.1382596;FeatureName:MUC16_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:831.000000|Direction: 1|PValue:0.03182281|FDR:0.1134198;FeatureName:12p13.32_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.247697|Direction: 1|PValue:0.01997785|FDR:0.2441694;FeatureName:1q31.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.270895|Direction:-1|PValue:0.01068587|FDR:0.2418970;FeatureName:3q26.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.290264|Direction:-1|PValue:0.00608224|FDR:0.8454308
FeatureName:synchronous_colon_cancer_present|Type:BIN|StatisticMethod:ranktest|GroupComparison:no/yes|Statistics:187|Direction:-1|PValue:0.0463685|FDR:0.615420;FeatureName:RYR1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:724|Direction: 1|PValue:0.0221218|FDR:0.252738
FeatureName:history_of_colon_polyps|Type:BIN|StatisticMethod:ranktest|GroupComparison:no/yes|Statistics:1205.000000|Direction: 1|PValue:0.0270744|FDR:0.995752;FeatureName:HMCN1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 372.000000|Direction:-1|PValue:0.0435912|FDR:0.674052;FeatureName:APC_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics: 902.000000|Direction: 1|PValue:0.0364367|FDR:0.361765;FeatureName:CSMD3_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 301.000000|Direction:-1|PValue:0.0205418|FDR:0.245535;FeatureName:DCHS2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 527.000000|Direction: 1|PValue:0.0387867|FDR:0.348297;FeatureName:17q24.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.229569|Direction:-1|PValue:0.0314307|FDR:0.805809;FeatureName:2q33.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.269108|Direction:-1|PValue:0.0112345|FDR:0.351583;FeatureName:10q25.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.222930|Direction:-1|PValue:0.0368235|FDR:0.689421
FeatureName:synchronous_colon_cancer_present|Type:BIN|StatisticMethod:ranktest|GroupComparison:no/yes|Statistics:500.000000|Direction: 1|PValue:0.01503462|FDR:0.4179625;FeatureName:DNAH2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:293.000000|Direction:-1|PValue:0.01590512|FDR:0.2002827;FeatureName:CSMD3_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:314.000000|Direction:-1|PValue:0.03059693|FDR:0.3008862;FeatureName:11p15.5_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.295618|Direction:-1|PValue:0.00516946|FDR:0.1557346;FeatureName:3p14.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.252877|Direction:-1|PValue:0.01745163|FDR:0.1516111;FeatureName:1p33_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.270061|Direction: 1|PValue:0.01093892|FDR:0.2646928;FeatureName:1p36.11_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.285193|Direction: 1|PValue:0.00707537|FDR:0.0468322;FeatureName:1p13.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.290486|Direction: 1|PValue:0.00604185|FDR:0.1479849
FeatureName:overall_survival|Type:SUR|StatisticMethod:Cox model|GroupComparison:|Statistics: -6.29604|Direction:-1|PValue:0.00109156|FDR:0.151726;FeatureName:PIK3CA_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:354.00000|Direction:-1|PValue:0.02639414|FDR:0.832001;FeatureName:8p11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.22280|Direction: 1|PValue:0.03693664|FDR:0.963919
FeatureName:Cancer|Type:BIN|StatisticMethod:ranktest|GroupComparison:colon/rectum|Statistics:636.000000|Direction:-1|PValue:0.0409532|FDR:0.406607;FeatureName:TTN_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:645.000000|Direction:-1|PValue:0.0310841|FDR:0.308621;FeatureName:PKHD1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:220.000000|Direction:-1|PValue:0.0350862|FDR:0.823986;FeatureName:13q22.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.229186|Direction:-1|PValue:0.0317223|FDR:0.164634;FeatureName:19p13.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.217117|Direction:-1|PValue:0.0421618|FDR:0.846732;FeatureName:1p36.11_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.242317|Direction: 1|PValue:0.0229269|FDR:0.105443;FeatureName:19p13.3_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.212209|Direction:-1|PValue:0.0471556|FDR:0.828579
FeatureName:tissue_site|Type:CAT|StatisticMethod:kruskal|GroupComparison:aa/ag/af/a6|Statistics:  8.257316|Direction: 1|PValue:0.04098259|FDR:0.4313129;FeatureName:lymphnode_pathologic_spread|Type:CAT|StatisticMethod:kruskal|GroupComparison:n0/n1/n2|Statistics:  9.667252|Direction: 1|PValue:0.00795762|FDR:0.2983074;FeatureName:person_neoplasm_cancer_status|Type:BIN|StatisticMethod:ranktest|GroupComparison:with tumor/tumor free|Statistics:332.000000|Direction: 1|PValue:0.03606886|FDR:0.6071302;FeatureName:SYNE1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:903.000000|Direction: 1|PValue:0.01884314|FDR:0.3979352;FeatureName:CUBN_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:720.000000|Direction: 1|PValue:0.00838405|FDR:0.0832906;FeatureName:FAT2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:610.000000|Direction: 1|PValue:0.03042757|FDR:0.3021023;FeatureName:FAM123B_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:498.000000|Direction: 1|PValue:0.02635263|FDR:0.4474745;FeatureName:HYDIN_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:628.000000|Direction: 1|PValue:0.01677259|FDR:0.2331390;FeatureName:11p15.5_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.223059|Direction:-1|PValue:0.03671171|FDR:0.2871035;FeatureName:3p14.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.222126|Direction: 1|PValue:0.03752582|FDR:0.2006188;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.244240|Direction:-1|PValue:0.02183270|FDR:0.0645690
FeatureName:person_neoplasm_cancer_status|Type:BIN|StatisticMethod:ranktest|GroupComparison:with tumor/tumor free|Statistics:339.000000|Direction: 1|PValue:0.0264559|FDR:0.549580;FeatureName:vascular_Invasion|Type:BIN|StatisticMethod:ranktest|GroupComparison:no/yes|Statistics:246.000000|Direction:-1|PValue:0.0448951|FDR:0.557325;FeatureName:CSMD2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:590.000000|Direction: 1|PValue:0.0168751|FDR:0.390940;FeatureName:20q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.212421|Direction: 1|PValue:0.0469300|FDR:0.112470;FeatureName:20q13.31_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.216608|Direction: 1|PValue:0.0426580|FDR:0.100499;FeatureName:16p13.3_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.272793|Direction: 1|PValue:0.0101288|FDR:0.129677;FeatureName:16q23.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.264986|Direction: 1|PValue:0.0125950|FDR:0.044890
FeatureName:lymphnode_pathologic_spread|Type:CAT|StatisticMethod:kruskal|GroupComparison:n0/n1/n2|Statistics:  7.49242|Direction: 1|PValue:0.0236071|FDR:0.298307;FeatureName:vascular_Invasion|Type:BIN|StatisticMethod:ranktest|GroupComparison:no/yes|Statistics:214.00000|Direction:-1|PValue:0.0133570|FDR:0.557325
FeatureName:person_neoplasm_cancer_status|Type:BIN|StatisticMethod:ranktest|GroupComparison:with tumor/tumor free|Statistics: 338.000000|Direction:1|PValue:0.02767671|FDR:0.5495805;FeatureName:DNAH2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 686.000000|Direction:1|PValue:0.02552493|FDR:0.2002827;FeatureName:TP53_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:1261.000000|Direction:1|PValue:0.00145533|FDR:0.0168576;FeatureName:CSMD3_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 709.000000|Direction:1|PValue:0.01221504|FDR:0.2455347;FeatureName:MDN1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 506.000000|Direction:1|PValue:0.01953100|FDR:0.2027842;FeatureName:11p15.5_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.224626|Direction:1|PValue:0.03537652|FDR:0.2871035;FeatureName:3p14.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.227191|Direction:1|PValue:0.03327988|FDR:0.1850361
FeatureName:tumor_stage|Type:CAT|StatisticMethod:kruskal|GroupComparison:stage ii/stage i/stage iii/stage iv|Statistics:  7.938239|Direction: 1|PValue:0.04730551|FDR:0.2026034;FeatureName:FLG_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:229.000000|Direction:-1|PValue:0.00152773|FDR:0.0416177;FeatureName:DCHS2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:163.000000|Direction:-1|PValue:0.00391618|FDR:0.2646812;FeatureName:5q22.3_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.212014|Direction: 1|PValue:0.04736397|FDR:0.5958574;FeatureName:20q13.31_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.218607|Direction:-1|PValue:0.04073542|FDR:0.0977042;FeatureName:5q11.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.278108|Direction: 1|PValue:0.00870166|FDR:0.5047537;FeatureName:21q11.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.241251|Direction: 1|PValue:0.02355347|FDR:0.9404110;FeatureName:18p11.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.240371|Direction: 1|PValue:0.02408180|FDR:0.0727689
FeatureName:SMAD4_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:575.000000|Direction: 1|PValue:0.0283054|FDR:0.565112;FeatureName:1q31.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.211735|Direction:-1|PValue:0.0476624|FDR:0.254811
FeatureName:MSI_status_TCGAPaper_threegroup|Type:CAT|StatisticMethod:kruskal|GroupComparison:MSS/MSI-L/MSI-H|Statistics:  7.680339|Direction: 1|PValue:0.02148995|FDR:0.0859281;FeatureName:silent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.274781|Direction: 1|PValue:0.01949404|FDR:0.0713071;FeatureName:SMAD4_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:597.000000|Direction: 1|PValue:0.01309899|FDR:0.5651123;FeatureName:FAT4_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:847.000000|Direction: 1|PValue:0.00881393|FDR:0.3062841;FeatureName:20q11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.236396|Direction:-1|PValue:0.02659494|FDR:0.0684573;FeatureName:20q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.225516|Direction:-1|PValue:0.03463740|FDR:0.0859750;FeatureName:20q13.31_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.243352|Direction:-1|PValue:0.02233277|FDR:0.0582633;FeatureName:8q12.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.213319|Direction:-1|PValue:0.04598550|FDR:0.6439379
FeatureName:lymphatic_invasion_present|Type:BIN|StatisticMethod:ranktest|GroupComparison:yes/no|Statistics: 533.000000|Direction:-1|PValue:0.00491771|FDR:0.3065972;FeatureName:synchronous_colon_cancer_present|Type:BIN|StatisticMethod:ranktest|GroupComparison:no/yes|Statistics: 152.000000|Direction:-1|PValue:0.01283712|FDR:0.4179625;FeatureName:MSI_status_TCGAPaper_threegroup|Type:CAT|StatisticMethod:kruskal|GroupComparison:MSS/MSI-L/MSI-H|Statistics:   7.916661|Direction: 1|PValue:0.01909496|FDR:0.0839819;FeatureName:MSI_status_TCGAPaper_twogroup|Type:BIN|StatisticMethod:ranktest|GroupComparison:MSS/MSI|Statistics: 433.000000|Direction:-1|PValue:0.01718322|FDR:0.0884617;FeatureName:TP53_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:1173.000000|Direction: 1|PValue:0.01729974|FDR:0.1001943;FeatureName:FAT2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 243.000000|Direction:-1|PValue:0.01409789|FDR:0.3002186;FeatureName:8q24.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.232326|Direction:-1|PValue:0.02939524|FDR:0.5159243;FeatureName:11p15.5_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.218594|Direction: 1|PValue:0.04074777|FDR:0.2871035;FeatureName:20q13.31_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.242823|Direction:-1|PValue:0.02263466|FDR:0.0582633;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.239273|Direction: 1|PValue:0.02475471|FDR:0.0688181
FeatureName:overall_survival|Type:SUR|StatisticMethod:Cox model|GroupComparison:|Statistics:  4.749616|Direction: 1|PValue:0.029880041|FDR:0.5437772;FeatureName:vascular_Invasion|Type:BIN|StatisticMethod:ranktest|GroupComparison:no/yes|Statistics:245.000000|Direction:-1|PValue:0.043354819|FDR:0.5573253;FeatureName:MSI_status_TCGAPaper_threegroup|Type:CAT|StatisticMethod:kruskal|GroupComparison:MSS/MSI-L/MSI-H|Statistics: 13.900187|Direction: 1|PValue:0.000958545|FDR:0.0133238;FeatureName:MSI_status_TCGAPaper_twogroup|Type:BIN|StatisticMethod:ranktest|GroupComparison:MSS/MSI|Statistics:455.000000|Direction:-1|PValue:0.030368538|FDR:0.1206065;FeatureName:nonsilent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.232219|Direction: 1|PValue:0.049659680|FDR:0.1448440
FeatureName:overall_survival|Type:SUR|StatisticMethod:Cox model|GroupComparison:|Statistics:-4.797834|Direction:-1|PValue:0.01591015|FDR:0.5437772;FeatureName:16p11.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: 0.299124|Direction: 1|PValue:0.00463978|FDR:0.0195433;FeatureName:18p11.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:-0.236980|Direction:-1|PValue:0.02621225|FDR:0.0775213
FeatureName:tumor_stage|Type:CAT|StatisticMethod:kruskal|GroupComparison:stage ii/stage i/stage iii/stage iv|Statistics:   8.549635|Direction:1|PValue:0.0359186|FDR:0.181240;FeatureName:KRAS_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:1124.000000|Direction:1|PValue:0.0453719|FDR:0.429476;FeatureName:1p33_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.222132|Direction:1|PValue:0.0375206|FDR:0.306786
FeatureName:KRAS_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:1142.000000|Direction: 1|PValue:0.03055104|FDR:0.3737211;FeatureName:20q11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.295140|Direction: 1|PValue:0.00524566|FDR:0.0191881;FeatureName:20q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.263981|Direction: 1|PValue:0.01294770|FDR:0.0428507;FeatureName:17q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.272210|Direction: 1|PValue:0.01029709|FDR:0.2955888;FeatureName:20q13.31_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.249560|Direction: 1|PValue:0.01903549|FDR:0.0515754;FeatureName:16p11.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.285860|Direction: 1|PValue:0.00693709|FDR:0.0247245;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.271929|Direction:-1|PValue:0.01037908|FDR:0.0335510;FeatureName:18q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.288980|Direction:-1|PValue:0.00632125|FDR:0.0237474;FeatureName:18p11.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.248571|Direction:-1|PValue:0.01953081|FDR:0.0616996
FeatureName:hypermutated|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:289.000000|Direction:-1|PValue:0.01826653|FDR:0.0619280;FeatureName:11p15.5_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.245226|Direction:-1|PValue:0.02128955|FDR:0.2242382;FeatureName:8p11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.260885|Direction:-1|PValue:0.01408836|FDR:0.9639189;FeatureName:1q31.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.226961|Direction: 1|PValue:0.03346381|FDR:0.2470558;FeatureName:3p14.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.316634|Direction:-1|PValue:0.00265098|FDR:0.0614143;FeatureName:1p36.11_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.241261|Direction: 1|PValue:0.02354796|FDR:0.1054426;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.273514|Direction: 1|PValue:0.00992381|FDR:0.0328431;FeatureName:10q21.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.283913|Direction: 1|PValue:0.00734782|FDR:0.3404492;FeatureName:10q23.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.274925|Direction: 1|PValue:0.00953350|FDR:0.4417188;FeatureName:15q11.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.229141|Direction: 1|PValue:0.03175708|FDR:0.4066697;FeatureName:15q21.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.255734|Direction: 1|PValue:0.01617978|FDR:0.2498878;FeatureName:10q25.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.271495|Direction: 1|PValue:0.01050688|FDR:0.6894213;FeatureName:3p26.3_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.276957|Direction:-1|PValue:0.00899477|FDR:0.3490183
FeatureName:person_neoplasm_cancer_status|Type:BIN|StatisticMethod:ranktest|GroupComparison:with tumor/tumor free|Statistics: 44.000000|Direction:-1|PValue:0.00308368|FDR:0.214316;FeatureName:DNAH5_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:287.000000|Direction:-1|PValue:0.01305835|FDR:0.973636;FeatureName:RYR1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:310.000000|Direction:-1|PValue:0.01340911|FDR:0.239848;FeatureName:FAM123B_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:124.000000|Direction:-1|PValue:0.00189311|FDR:0.263142;FeatureName:1p33_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.236341|Direction: 1|PValue:0.02663126|FDR:0.290605;FeatureName:6p25.3_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.232450|Direction:-1|PValue:0.02930660|FDR:0.509202;FeatureName:10q21.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.228900|Direction: 1|PValue:0.03194156|FDR:0.549375;FeatureName:10q23.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.287775|Direction: 1|PValue:0.00655313|FDR:0.441719;FeatureName:10q25.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.239673|Direction: 1|PValue:0.02450780|FDR:0.689421
FeatureName:LRP1B_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:702.000000|Direction: 1|PValue:0.0153957|FDR:0.251504;FeatureName:13q12.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.216242|Direction: 1|PValue:0.0430184|FDR:0.175869;FeatureName:3q26.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.242076|Direction:-1|PValue:0.0230674|FDR:0.900500;FeatureName:10q21.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.210792|Direction: 1|PValue:0.0486849|FDR:0.615201
FeatureName:hypermutated|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:631.000000|Direction: 1|PValue:0.03067373|FDR:0.0870132;FeatureName:SDK1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics: 94.000000|Direction:-1|PValue:0.04878763|FDR:0.4320521;FeatureName:LRP1B_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:728.000000|Direction: 1|PValue:0.00631456|FDR:0.2515037;FeatureName:TP53_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:674.000000|Direction:-1|PValue:0.04419135|FDR:0.1462523;FeatureName:SMAD4_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:560.000000|Direction: 1|PValue:0.04586467|FDR:0.5651123;FeatureName:TTN_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:622.000000|Direction:-1|PValue:0.01804950|FDR:0.2280800;FeatureName:MUC16_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:834.000000|Direction: 1|PValue:0.02938558|FDR:0.1103945;FeatureName:LRP2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:311.000000|Direction:-1|PValue:0.02796194|FDR:0.2225364;FeatureName:17q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.286929|Direction:-1|PValue:0.00672051|FDR:0.2955888;FeatureName:13q12.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.298960|Direction: 1|PValue:0.00466334|FDR:0.0498619;FeatureName:13q12.13_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.274581|Direction: 1|PValue:0.00962748|FDR:0.0787188;FeatureName:16q23.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.249945|Direction: 1|PValue:0.01884543|FDR:0.0623694
FeatureName:history_of_colon_polyps|Type:BIN|StatisticMethod:ranktest|GroupComparison:no/yes|Statistics:1206.000000|Direction: 1|PValue:0.0264992|FDR:0.995752;FeatureName:TP53_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 672.000000|Direction:-1|PValue:0.0423415|FDR:0.146252;FeatureName:CSMD3_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 316.000000|Direction:-1|PValue:0.0324697|FDR:0.300886;FeatureName:17q24.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.238279|Direction:-1|PValue:0.0253777|FDR:0.805809;FeatureName:2q33.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.221881|Direction:-1|PValue:0.0377429|FDR:0.476933;FeatureName:10q25.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.227157|Direction:-1|PValue:0.0333068|FDR:0.689421
FeatureName:distant_metastasis_pathologic_spread|Type:BIN|StatisticMethod:ranktest|GroupComparison:m0/m1|Statistics: 600.000000|Direction: 1|PValue:0.04209671|FDR:0.2152418;FeatureName:lymphnode_pathologic_spread|Type:CAT|StatisticMethod:kruskal|GroupComparison:n0/n1/n2|Statistics:   7.871410|Direction: 1|PValue:0.01953192|FDR:0.2983074;FeatureName:TP53_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:1155.000000|Direction: 1|PValue:0.02653417|FDR:0.1189758;FeatureName:20q11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.309917|Direction:-1|PValue:0.00329888|FDR:0.0127374;FeatureName:20q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.277067|Direction:-1|PValue:0.00896653|FDR:0.0319576;FeatureName:20q13.31_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.296601|Direction:-1|PValue:0.00501581|FDR:0.0181008;FeatureName:16p11.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.220380|Direction:-1|PValue:0.03909132|FDR:0.0936844;FeatureName:8q12.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.230102|Direction:-1|PValue:0.03102768|FDR:0.6161210;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.261449|Direction: 1|PValue:0.01387440|FDR:0.0438305